{"id":648,"date":"2026-11-18T09:00:00","date_gmt":"2026-11-18T09:00:00","guid":{"rendered":"https:\/\/clinicanering.com\/blog\/?p=648"},"modified":"2026-10-29T04:37:24","modified_gmt":"2026-10-29T04:37:24","slug":"weight-loss-injections-thyroid-cancer","status":"publish","type":"post","link":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/","title":{"rendered":"Do Ozempic and Mounjaro Cause Thyroid Cancer? What the Studies Show"},"content":{"rendered":"<blockquote>\n<p><strong>Main points<\/strong><\/p>\n<ul>\n<li>The warning on the Ozempic and Mounjaro labels came from studies in rodents, which developed a rare type of thyroid cancer, medullary cancer, on these drugs.<\/li>\n<li>In studies where people were randomly assigned to take the drug or not, this type of cancer did not increase, but there were few cases.<\/li>\n<li>For the most common thyroid cancer, some studies found an increase and others did not. Part of the increase may come from more testing.<\/li>\n<li>In absolute numbers, the extra risk was very small: in the 2024 review, about 1 extra case for every 1,349 people treated for 5 years.<\/li>\n<li>People with a personal or family history of medullary thyroid cancer should not use these injections.<\/li>\n<\/ul>\n<\/blockquote>\n<p>Anyone who starts Ozempic, Mounjaro or another weight-loss injection and reads the label gets a fright: there is a warning about thyroid cancer. Many people become afraid to start treatment because of it.<\/p>\n<p>It is a fair concern, and in this post I explain where that warning came from, what studies in people show so far and who should not use these drugs. If you want to understand first how the injections work, I wrote about it in the post on <a href=\"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-mounjaro-ozempic\/\">weight-loss injections<\/a>.<\/p>\n<h2>What we know so far about Ozempic, Mounjaro and thyroid cancer<\/h2>\n<p>So far, studies in people have not shown that Ozempic, Mounjaro and the other injections in the same family cause thyroid cancer. The label warning came from studies in rats and mice. For medullary cancer, the rare type seen in the animals, randomized studies in people found no increase. For the common type, some studies found a <strong>small increase<\/strong> and others found nothing. The contraindication still applies to anyone who has had medullary cancer or has a relative who had it. These are the main studies:<\/p>\n<table>\n<colgroup>\n<col style=\"width: 33%\" \/>\n<col style=\"width: 33%\" \/>\n<col style=\"width: 33%\" \/>\n<\/colgroup>\n<thead>\n<tr>\n<th>Study<\/th>\n<th>How it was done<\/th>\n<th>What it found<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>LEADER (2018)<\/td>\n<td>randomized, 9,340 people with diabetes, liraglutide or placebo<\/td>\n<td>no medullary cancer on the drug; calcitonin did not rise<\/td>\n<\/tr>\n<tr>\n<td>France (2023)<\/td>\n<td>observational, 2,562 people with thyroid cancer compared with 45,000 without it<\/td>\n<td>more thyroid cancer after 1 to 3 years of use<\/td>\n<\/tr>\n<tr>\n<td>Review of 64 studies (2024)<\/td>\n<td>randomized studies lasting at least 1 year<\/td>\n<td>fragile increase, 1 extra case for every 1,349 people treated for 5 years<\/td>\n<\/tr>\n<tr>\n<td>Scandinavia (2024)<\/td>\n<td>observational, 145,000 people who started an injection<\/td>\n<td>no increase compared with another diabetes drug<\/td>\n<\/tr>\n<tr>\n<td>Review of 50 studies (2025)<\/td>\n<td>randomized studies, all types of cancer<\/td>\n<td>overall cancer did not increase; a thyroid signal again<\/td>\n<\/tr>\n<tr>\n<td>New York (2026)<\/td>\n<td>observational, 1,072 people who already had thyroid cancer<\/td>\n<td>no more recurrence or progression of the cancer with the injections<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Where this fear came from<\/h2>\n<p>The drugs in this family, such as semaglutide (in Ozempic and Wegovy), tirzepatide (in Mounjaro) and liraglutide, mimic a gut hormone called GLP-1. According to the Wegovy and Mounjaro labels, in studies in rats (and, with semaglutide, also in mice), they stimulated the C cells of the thyroid, which produce a hormone called calcitonin. The tumors became more frequent as the dose and the length of use went up, including at doses similar to those used in people, and some animals developed medullary thyroid cancer.<\/p>\n<p>In monkeys treated with liraglutide for 20 months, this effect did not appear, and the label itself says it is not known whether it happens in people. Even so, the US drug agency, the FDA, put a <strong>boxed warning<\/strong> on the label, and the drugs became contraindicated for people with a personal or family history of this type of cancer.<\/p>\n<h2>The two types of thyroid cancer that matter here<\/h2>\n<p>The thyroid is a small, butterfly-shaped gland at the front of the neck. It produces the hormones that regulate <a href=\"https:\/\/clinicanering.com\/blog\/en\/body-composition\/metabolism-calories-burned-at-rest\/\">metabolism<\/a>, and nodules in it are very common, especially in women. Most of the time these nodules are benign, and thyroid cancer is much less common. To understand the studies, it helps to separate two types:<\/p>\n<ul>\n<li>medullary cancer, which arises from the C cells and was the type seen in the animals. According to the 2015 American guideline on this tumor, it accounts for <strong>1% to 2% of thyroid cancers<\/strong> in the United States;<\/li>\n<li>differentiated cancer, which arises from the cells that make thyroid hormone. It is the most common type and, most of the time, it is treatable and has a good outlook. In a small 2012 study, 3 of the 17 tumors of this type that were analyzed had the GLP-1 receptor, and that led researchers to look into whether the injections could stimulate this cancer.<\/li>\n<\/ul>\n<h2>How to read the studies on this topic<\/h2>\n<p>In a randomized study, researchers split people by drawing lots: some take the drug and some do not. Because the groups end up alike in everything, a difference that shows up at the end tends to be an effect of the drug. The problem is that these studies last only a few years and thyroid cancer is rare, so few cases appear.<\/p>\n<p>In an observational study, researchers look at the health records of thousands of people who were already taking the drug or not. It picks up more cases and follows people for longer, but those who use the injections may differ from those who do not in many ways, such as weight, diabetes and the number of doctor visits. That is why it <strong>shows an association and does not prove cause<\/strong>.<\/p>\n<h2>What studies in people show about medullary cancer<\/h2>\n<p>The LEADER trial followed more than 9,000 people with type 2 diabetes for three and a half to five years, half on liraglutide and half on placebo. Calcitonin, which rises when C cells grow too much, did not increase with the drug. And there was <strong>not a single case of medullary cancer<\/strong> or of abnormal C-cell growth among those who took liraglutide.<\/p>\n<p>In the 2024 review, which pooled the randomized studies, medullary cancer did not increase significantly either, but there were very few cases. A French observational study, which I describe below, did see more cases of the medullary type in people who had used these drugs for one to three years. Researchers are still following this signal, and, as a precaution, the contraindication for people with a history of this cancer still stands.<\/p>\n<h2>What about the most common thyroid cancer?<\/h2>\n<p>For the common thyroid cancer, the studies on Ozempic and the other injections do not agree with each other. A French study and a review of randomized studies found an increase, while one of the largest studies ever done, with data from three countries, did not.<\/p>\n<h3>The studies that found an increase<\/h3>\n<p>A French study compared thousands of people with diabetes who had thyroid cancer with similar people who did not. Those who had used these drugs for one to three years had a higher risk of thyroid cancer. It is an observational study, which shows an association but does not prove that the drug caused the cancer.<\/p>\n<p>A 2024 review pooled 64 studies in which participants were randomly assigned to the injections or another treatment for at least one year. It also found more cases of thyroid cancer with the injections. But the result was fragile: one fewer case in the injection group would have been enough for it to stop being statistically significant. And, in absolute numbers, the extra risk was about <strong>one extra case for every 1,349<\/strong> people treated for five years.<\/p>\n<h3>A large study that found no increase<\/h3>\n<p>One of the largest studies on the subject used the health registries of Denmark, Norway and Sweden. It followed more than 145,000 people with diabetes who started an injection and compared them with people who started another type of diabetes drug. Thyroid cancer appeared at a similar rate in both groups, <strong>with no real difference<\/strong>. A second comparison, with a third type of diabetes drug, also showed no clear difference, but with a wide margin of error. Medullary cancer was analyzed too, but there were so few cases that no conclusion could be drawn.<\/p>\n<figure class=\"nering-chart\">\n<img decoding=\"async\" src=\"\/blog\/wp-content\/uploads\/tireoide-casos-escandinavia-en.svg\" alt=\"Bar chart of thyroid cancer cases per 10,000 people per year among people with diabetes in Denmark, Norway and Sweden: 1.33 among those who started an injection and 1.46 among those who started another diabetes drug.\" width=\"640\" height=\"400\" loading=\"lazy\"><br \/>\n<\/figure>\n<p>Look at the scale: a little over one case for every 10,000 people per year, in both groups. Thyroid cancer is uncommon to begin with, with or without the injections.<\/p>\n<h3>Why the results differ<\/h3>\n<p>One likely explanation is that people who start a new drug see the doctor more often and have more tests. Since many thyroid cancers are small and cause no symptoms, people who are examined more end up with more diagnoses, without the drug having caused anything. The authors of the 2026 New York study, which I describe further down, point out that part of the increase seen early in treatment may come from this <strong>closer surveillance<\/strong>.<\/p>\n<p>Another point is that excess weight on its own raises the risk of thyroid cancer, according to the World Health Organization&#8217;s cancer agency. People who use the injections usually already have obesity or diabetes, and that muddies the comparison in observational studies. In randomized studies the groups start out alike, so this explanation does not apply to them.<\/p>\n<h2>What about cancer risk in general?<\/h2>\n<p>A 2025 review pooled 50 randomized studies of these injections and looked at all types of cancer. <strong>The overall risk of cancer did not increase.<\/strong> In the studies in people with obesity, uterine cancer even went down. The thyroid signal showed up again, in an analysis that includes many of the same studies as the earlier review. There was also an increase in bowel cancer, only in the shorter studies, and the authors think it may have come from extra tests done because of the gut symptoms the injections cause.<\/p>\n<h2>Mounjaro and Ozempic for people who have had thyroid cancer<\/h2>\n<p>Until recently, there was little data on the injections in people who had already been treated for the common type of thyroid cancer and needed to lose weight. A study published in 2026 by a major cancer center in New York helped answer this. The researchers compared 536 people who already had differentiated thyroid cancer and used the injections with 536 similar people who did not. After about six years of follow-up, those who used the injections had a <strong>similar chance of the cancer coming back or getting worse<\/strong>, with no difference between the groups.<\/p>\n<p>The study looked back at medical records, and half of the people used the injections for less than a year and four months, so longer studies are still needed. Even so, the authors concluded that people with this type of cancer who need the injections should not go without treatment just because of it. In practice, you make this decision together with the endocrinologist who follows your thyroid. When people stop the injections, much of the weight usually comes back, as I showed in the post on <a href=\"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/stopping-weight-loss-injections-does-weight-come-back\/\">stopping the injections<\/a>.<\/p>\n<h2>Medullary thyroid cancer: who should not use Ozempic or Mounjaro<\/h2>\n<p>The thyroid rules out the injections only in very specific situations, all of them linked to medullary cancer. According to the labels, the contraindication still applies to:<\/p>\n<ul>\n<li>people who have had medullary cancer;<\/li>\n<li>people whose father, mother, brother, sister or another relative has had this cancer;<\/li>\n<li>people with the rare genetic syndrome called MEN 2, which greatly raises the risk of this cancer.<\/li>\n<\/ul>\n<p>Most cases of thyroid cancer in a family are the common type, which does not fall under this contraindication. Before starting the injections, I suggest checking four things:<\/p>\n<ol type=\"1\">\n<li>Ask your family whether anyone has had thyroid cancer and what type it was. If it was medullary, talk to your doctor about genetic testing, because some of these cases are inherited.<\/li>\n<li>Tell your doctor if you have a thyroid nodule or have been treated for thyroid cancer.<\/li>\n<li>Do not get a calcitonin test or a thyroid ultrasound just because of the injections. The label says these routine tests are of uncertain value; they are used when there is a nodule, a symptom or medullary cancer in the family.<\/li>\n<li>During treatment, watch for the signs in the section below.<\/li>\n<\/ol>\n<p>People with the contraindication can still lose weight through diet and training. I wrote about how to do it without losing muscle in the post on <a href=\"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/lose-weight-without-losing-muscle\/\">losing weight without losing muscle mass<\/a>.<\/p>\n<h2>Signs to watch for<\/h2>\n<p>The signs that deserve attention show up in the neck and throat. The label advises getting checked if, during treatment, you notice:<\/p>\n<ul>\n<li>a <strong>lump or swelling in the neck<\/strong>;<\/li>\n<li>hoarseness that does not go away;<\/li>\n<li>trouble swallowing;<\/li>\n<li>unexplained shortness of breath.<\/li>\n<\/ul>\n<p>Most of the time, these signs have another cause, such as a benign nodule, but they should be examined. If you are wondering which injection to choose, I wrote about <a href=\"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/which-weight-loss-injection-works-best\/\">which injection leads to the most weight loss<\/a>.<\/p>\n<h2>Conclusion<\/h2>\n<p>The thyroid cancer warning on the Ozempic and Mounjaro labels started with studies in rodents and, so far, has not been confirmed for medullary cancer in randomized studies in people. For the common thyroid cancer, the studies are split: some found a small increase, which may be partly explained by more testing, and one of the largest studies found no increase. In the data we have so far, the extra risk measured was very low, and for tirzepatide, which is newer, there is even less long-term data. The rule that still holds is not to use the injections when there is a personal or family history of medullary cancer.<\/p>\n<p>See you in the next post!<\/p>\n<hr \/>\n<p><strong>Responsible physician:<\/strong> <a href=\"https:\/\/clinicanering.com\/sobre\/\">Dr. Gilberto Nering Junior<\/a>, <a href=\"https:\/\/clinicanering.com\/medicina-do-esporte\/\">sports medicine physician<\/a>, CRM-SP 160822, RQE 142486 (Sports Medicine, Brazil).<\/p>\n<p><small>This text was not sponsored, is for information only and does not replace an individual assessment. Questions about the content: <a href=\"https:\/\/clinicanering.com\/contato\/\">contact the clinic<\/a>.<\/small><\/p>\n<p>Cover photo: <a href=\"https:\/\/unsplash.com\/photos\/woman-in-white-tank-top-gUPznplBsLI\">El S<\/a> on Unsplash.<\/p>\n<div class=\"nering-faq\">\n<h2>Frequently asked questions about Ozempic, Mounjaro and thyroid cancer<\/h2>\n<h3>Does Ozempic cause thyroid cancer?<\/h3>\n<p>So far, there is no proof that semaglutide, the drug in Ozempic and Wegovy, causes thyroid cancer in people. The warning came from studies in rodents. For the common thyroid cancer, some studies saw a small increase and others saw none.<\/p>\n<h3>Can people with a thyroid nodule use Ozempic or Mounjaro?<\/h3>\n<p>A common thyroid nodule is not a contraindication. The doctor evaluates the nodule as usual, and you decide about the injections together with the doctor who follows your thyroid.<\/p>\n<h3>Can people who have had thyroid cancer use Ozempic or Mounjaro?<\/h3>\n<p>In a 2026 study, people who had differentiated thyroid cancer, the most common type, and used the injections had a similar chance of the disease coming back as those who did not. The study included people who already had differentiated cancer; people who are only under surveillance for a small cancer, without surgery, make that decision with their endocrinologist. People who have had the medullary type should not use them.<\/p>\n<h3>Does Mounjaro cause thyroid cancer?<\/h3>\n<p>So far, there is no proof that Mounjaro causes thyroid cancer. Tirzepatide, the drug in Mounjaro, acts on the same GLP-1 receptor (and also on the receptor for another gut hormone, GIP) and carries the same warning on the label, with the same contraindication for people with a personal or family history of medullary cancer. Because it is newer, there is still less long-term data.<\/p>\n<h3>Do I need an ultrasound or a calcitonin test before starting?<\/h3>\n<p>The label itself says that routine calcitonin testing or thyroid ultrasound in people using the injections is of uncertain value. These tests are used when there is a nodule, a symptom or a family history of medullary cancer.<\/p>\n<h3>Which thyroid symptoms should raise concern during treatment?<\/h3>\n<p>A lump or swelling in the neck, hoarseness that does not go away, trouble swallowing and unexplained shortness of breath. Most of the time these symptoms have another cause, but they are still worth having checked.<\/p>\n<\/div>\n<h2>References<\/h2>\n<ol type=\"1\">\n<li>Bezin J, Gouverneur A, P\u00e9nichon M, et al.\u00a0GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. <em>Diabetes Care<\/em>. 2023;46(2):384-390. <a href=\"https:\/\/doi.org\/10.2337\/dc22-1148\">doi:10.2337\/dc22-1148<\/a><\/li>\n<li>Eli Lilly and Company. Mounjaro (tirzepatide) injection: prescribing information. DailyMed, US National Library of Medicine; 2026. Accessed October 17, 2026. <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=d2d7da5d-ad07-4228-955f-cf7e355c8cc0\">dailymed.nlm.nih.gov<\/a><\/li>\n<li>Heged\u00fcs L, Sherman SI, Tuttle RM, et al.\u00a0No Evidence of Increase in Calcitonin Concentrations or Development of C-Cell Malignancy in Response to Liraglutide for Up to 5 Years in the LEADER Trial. <em>Diabetes Care<\/em>. 2018;41(3):620-622. <a href=\"https:\/\/doi.org\/10.2337\/dc17-1956\">doi:10.2337\/dc17-1956<\/a><\/li>\n<li>Novo Nordisk. Wegovy (semaglutide) injection: prescribing information. DailyMed, US National Library of Medicine; 2026. Accessed October 17, 2026. <a href=\"https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b\">dailymed.nlm.nih.gov<\/a><\/li>\n<li>Pasternak B, Wintzell V, Hviid A, et al.\u00a0Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study. <em>BMJ<\/em>. 2024;385:e078225. <a href=\"https:\/\/doi.org\/10.1136\/bmj-2023-078225\">doi:10.1136\/bmj-2023-078225<\/a><\/li>\n<li>Patrizio A, Mauguen A, Fagin JA, et al.\u00a0Exposure to GLP-1RA and Risk of Structural Progression in Differentiated Thyroid Cancer. <em>J Clin Endocrinol Metab<\/em>. 2026;111(7):e1795-e1804. <a href=\"https:\/\/doi.org\/10.1210\/clinem\/dgag051\">doi:10.1210\/clinem\/dgag051<\/a><\/li>\n<li>Silverii GA, Marinelli C, Bettarini C, et al.\u00a0GLP-1 receptor agonists and the risk for cancer: A meta-analysis of randomized controlled trials. <em>Diabetes Obes Metab<\/em>. 2025;27(8):4454-4468. <a href=\"https:\/\/doi.org\/10.1111\/dom.16489\">doi:10.1111\/dom.16489<\/a><\/li>\n<li>Silverii GA, Monami M, Gallo M, et al.\u00a0Glucagon-like peptide-1 receptor agonists and risk of thyroid cancer: A systematic review and meta-analysis of randomized controlled trials. <em>Diabetes Obes Metab<\/em>. 2024;26(3):891-900. <a href=\"https:\/\/doi.org\/10.1111\/dom.15382\">doi:10.1111\/dom.15382<\/a><\/li>\n<li>Wells SA Jr, Asa SL, Dralle H, et al.\u00a0Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. <em>Thyroid<\/em>. 2015;25(6):567-610. <a href=\"https:\/\/doi.org\/10.1089\/thy.2014.0335\">doi:10.1089\/thy.2014.0335<\/a><\/li>\n<li>Bjerre Knudsen L, Madsen LW, Andersen S, et al.\u00a0Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation. <em>Endocrinology<\/em>. 2010;151(4):1473-1486. <a href=\"https:\/\/doi.org\/10.1210\/en.2009-1272\">doi:10.1210\/en.2009-1272<\/a><\/li>\n<li>Gier B, Butler PC, Lai CK, et al.\u00a0Glucagon like peptide-1 receptor expression in the human thyroid gland. <em>J Clin Endocrinol Metab<\/em>. 2012;97(1):121-131. <a href=\"https:\/\/doi.org\/10.1210\/jc.2011-2407\">doi:10.1210\/jc.2011-2407<\/a><\/li>\n<li>Lauby-Secretan B, Scoccianti C, Loomis D, et al.\u00a0Body Fatness and Cancer: Viewpoint of the IARC Working Group. <em>N Engl J Med<\/em>. 2016;375(8):794-798. <a href=\"https:\/\/doi.org\/10.1056\/NEJMsr1606602\">doi:10.1056\/NEJMsr1606602<\/a><\/li>\n<\/ol>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"FAQPage\", \"inLanguage\": \"en\", \"mainEntity\": [{\"@type\": \"Question\", \"name\": \"Does Ozempic cause thyroid cancer?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"So far, there is no proof that semaglutide, the drug in Ozempic and Wegovy, causes thyroid cancer in people. The warning came from studies in rodents. For the common thyroid cancer, some studies saw a small increase and others saw none.\"}}, {\"@type\": \"Question\", \"name\": \"Can people with a thyroid nodule use Ozempic or Mounjaro?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"A common thyroid nodule is not a contraindication. The doctor evaluates the nodule as usual, and you decide about the injections together with the doctor who follows your thyroid.\"}}, {\"@type\": \"Question\", \"name\": \"Can people who have had thyroid cancer use Ozempic or Mounjaro?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"In a 2026 study, people who had differentiated thyroid cancer, the most common type, and used the injections had a similar chance of the disease coming back as those who did not. The study included people who already had differentiated cancer; people who are only under surveillance for a small cancer, without surgery, make that decision with their endocrinologist. People who have had the medullary type should not use them.\"}}, {\"@type\": \"Question\", \"name\": \"Does Mounjaro cause thyroid cancer?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"So far, there is no proof that Mounjaro causes thyroid cancer. Tirzepatide, the drug in Mounjaro, acts on the same GLP-1 receptor (and also on the receptor for another gut hormone, GIP) and carries the same warning on the label, with the same contraindication for people with a personal or family history of medullary cancer. Because it is newer, there is still less long-term data.\"}}, {\"@type\": \"Question\", \"name\": \"Do I need an ultrasound or a calcitonin test before starting?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"The label itself says that routine calcitonin testing or thyroid ultrasound in people using the injections is of uncertain value. These tests are used when there is a nodule, a symptom or a family history of medullary cancer.\"}}, {\"@type\": \"Question\", \"name\": \"Which thyroid symptoms should raise concern during treatment?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"A lump or swelling in the neck, hoarseness that does not go away, trouble swallowing and unexplained shortness of breath. Most of the time these symptoms have another cause, but they are still worth having checked.\"}}]}<\/script><\/p>\n<p><script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@graph\": [{\"@type\": \"Organization\", \"@id\": \"https:\/\/clinicanering.com\/#org\", \"name\": \"Cl\u00ednica Nering\", \"url\": \"https:\/\/clinicanering.com\"}, {\"@type\": \"Person\", \"@id\": \"https:\/\/clinicanering.com\/#dr-gilberto\", \"name\": \"Dr. Gilberto Nering Junior\", \"jobTitle\": \"Sports Medicine Physician\", \"identifier\": \"CRM-SP 160822 \/ RQE 142486\", \"worksFor\": {\"@id\": \"https:\/\/clinicanering.com\/#org\"}, \"sameAs\": [\"https:\/\/www.doctoralia.com.br\/gilberto-nering-junior\", \"https:\/\/www.instagram.com\/clinica.nering\"]}, {\"@type\": \"MedicalWebPage\", \"@id\": \"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/#webpage\", \"url\": \"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/\", \"name\": \"Do Ozempic and Mounjaro Cause Thyroid Cancer?\", \"inLanguage\": \"en\", \"datePublished\": \"2026-11-18T09:00:00+00:00\", \"dateModified\": \"2026-11-18T09:00:00+00:00\", \"author\": {\"@id\": \"https:\/\/clinicanering.com\/#dr-gilberto\"}, \"reviewedBy\": {\"@id\": \"https:\/\/clinicanering.com\/#dr-gilberto\"}, \"publisher\": {\"@id\": \"https:\/\/clinicanering.com\/#org\"}, \"isPartOf\": {\"@type\": \"WebSite\", \"name\": \"Cl\u00ednica Nering Blog\", \"url\": \"https:\/\/clinicanering.com\/blog\/\"}}]}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Do Ozempic and Mounjaro cause thyroid cancer? The warning came from rat studies, and in people the extra risk was very small. See who should not use them.<\/p>\n","protected":false},"author":1,"featured_media":299,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[74],"tags":[],"class_list":["post-648","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-weight-loss","entry entry-center"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Do Ozempic and Mounjaro Cause Thyroid Cancer?<\/title>\n<meta name=\"description\" content=\"Do Ozempic and Mounjaro cause thyroid cancer? The warning came from rat studies, and in people the extra risk was very small. See who should not use them.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Do Ozempic and Mounjaro Cause Thyroid Cancer?\" \/>\n<meta property=\"og:description\" content=\"Do Ozempic and Mounjaro cause thyroid cancer? The warning came from rat studies, and in people the extra risk was very small. See who should not use them.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog Cl\u00ednica Nering\" \/>\n<meta property=\"article:published_time\" content=\"2026-11-18T09:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/clinicanering.com\/blog\/wp-content\/uploads\/caneta-emagrecimento-cancer-de-tireoide-capa.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"840\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Dr. Gilberto Nering Junior\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dr. Gilberto Nering Junior\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"14 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/\"},\"author\":{\"name\":\"Dr. Gilberto Nering Junior\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/#\\\/schema\\\/person\\\/7ad6b0ae64865ab53b092185769b59d3\"},\"headline\":\"Do Ozempic and Mounjaro Cause Thyroid Cancer? What the Studies Show\",\"datePublished\":\"2026-11-18T09:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/\"},\"wordCount\":2884,\"publisher\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/wp-content\\\/uploads\\\/caneta-emagrecimento-cancer-de-tireoide-capa.webp\",\"articleSection\":[\"Weight Loss\"],\"inLanguage\":\"pt-BR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/\",\"url\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/\",\"name\":\"Do Ozempic and Mounjaro Cause Thyroid Cancer?\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/wp-content\\\/uploads\\\/caneta-emagrecimento-cancer-de-tireoide-capa.webp\",\"datePublished\":\"2026-11-18T09:00:00+00:00\",\"description\":\"Do Ozempic and Mounjaro cause thyroid cancer? The warning came from rat studies, and in people the extra risk was very small. See who should not use them.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/wp-content\\\/uploads\\\/caneta-emagrecimento-cancer-de-tireoide-capa.webp\",\"contentUrl\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/wp-content\\\/uploads\\\/caneta-emagrecimento-cancer-de-tireoide-capa.webp\",\"width\":1600,\"height\":840,\"caption\":\"Pesco\u00e7o e ombros de uma mulher de regata branca, vistos de perto\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/en\\\/weight-loss\\\/weight-loss-injections-thyroid-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Do Ozempic and Mounjaro Cause Thyroid Cancer? What the Studies Show\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/#website\",\"url\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/\",\"name\":\"Cl\u00ednica Nering\",\"description\":\"Performance e Sa\u00fade\",\"publisher\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/#organization\",\"name\":\"Cl\u00ednica Nering\",\"url\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blog.clinicanering.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Design-sem-nome.png\",\"contentUrl\":\"https:\\\/\\\/blog.clinicanering.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Design-sem-nome.png\",\"width\":1563,\"height\":1563,\"caption\":\"Cl\u00ednica Nering\"},\"image\":{\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.instagram.com\\\/clinica.nering\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/#\\\/schema\\\/person\\\/7ad6b0ae64865ab53b092185769b59d3\",\"name\":\"Dr. Gilberto Nering Junior\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/clinicanering.com\\\/wp-content\\\/themes\\\/Clinica%20Nering\\\/assets\\\/images\\\/relume-254303-p-800.jpeg\",\"url\":\"https:\\\/\\\/clinicanering.com\\\/wp-content\\\/themes\\\/Clinica%20Nering\\\/assets\\\/images\\\/relume-254303-p-800.jpeg\",\"contentUrl\":\"https:\\\/\\\/clinicanering.com\\\/wp-content\\\/themes\\\/Clinica%20Nering\\\/assets\\\/images\\\/relume-254303-p-800.jpeg\",\"caption\":\"Dr. Gilberto Nering Junior\"},\"description\":\"M\u00e9dico do Esporte, Nutr\u00f3logo. Especialista em performance, emagrecimento e sa\u00fade metab\u00f3lica. Autor de \u201cO Guia Completo de Beach Tennis\u201d.\",\"sameAs\":[\"https:\\\/\\\/blog.clinicanering.com\"],\"url\":\"https:\\\/\\\/clinicanering.com\\\/blog\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Do Ozempic and Mounjaro Cause Thyroid Cancer?","description":"Do Ozempic and Mounjaro cause thyroid cancer? The warning came from rat studies, and in people the extra risk was very small. See who should not use them.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/","og_locale":"pt_PT","og_type":"article","og_title":"Do Ozempic and Mounjaro Cause Thyroid Cancer?","og_description":"Do Ozempic and Mounjaro cause thyroid cancer? The warning came from rat studies, and in people the extra risk was very small. See who should not use them.","og_url":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/","og_site_name":"Blog Cl\u00ednica Nering","article_published_time":"2026-11-18T09:00:00+00:00","og_image":[{"width":1600,"height":840,"url":"https:\/\/clinicanering.com\/blog\/wp-content\/uploads\/caneta-emagrecimento-cancer-de-tireoide-capa.webp","type":"image\/webp"}],"author":"Dr. Gilberto Nering Junior","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Dr. Gilberto Nering Junior","Tempo estimado de leitura":"14 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/#article","isPartOf":{"@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/"},"author":{"name":"Dr. Gilberto Nering Junior","@id":"https:\/\/clinicanering.com\/blog\/#\/schema\/person\/7ad6b0ae64865ab53b092185769b59d3"},"headline":"Do Ozempic and Mounjaro Cause Thyroid Cancer? What the Studies Show","datePublished":"2026-11-18T09:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/"},"wordCount":2884,"publisher":{"@id":"https:\/\/clinicanering.com\/blog\/#organization"},"image":{"@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/clinicanering.com\/blog\/wp-content\/uploads\/caneta-emagrecimento-cancer-de-tireoide-capa.webp","articleSection":["Weight Loss"],"inLanguage":"pt-BR"},{"@type":"WebPage","@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/","url":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/","name":"Do Ozempic and Mounjaro Cause Thyroid Cancer?","isPartOf":{"@id":"https:\/\/clinicanering.com\/blog\/#website"},"primaryImageOfPage":{"@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/#primaryimage"},"image":{"@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/clinicanering.com\/blog\/wp-content\/uploads\/caneta-emagrecimento-cancer-de-tireoide-capa.webp","datePublished":"2026-11-18T09:00:00+00:00","description":"Do Ozempic and Mounjaro cause thyroid cancer? The warning came from rat studies, and in people the extra risk was very small. See who should not use them.","breadcrumb":{"@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/#primaryimage","url":"https:\/\/clinicanering.com\/blog\/wp-content\/uploads\/caneta-emagrecimento-cancer-de-tireoide-capa.webp","contentUrl":"https:\/\/clinicanering.com\/blog\/wp-content\/uploads\/caneta-emagrecimento-cancer-de-tireoide-capa.webp","width":1600,"height":840,"caption":"Pesco\u00e7o e ombros de uma mulher de regata branca, vistos de perto"},{"@type":"BreadcrumbList","@id":"https:\/\/clinicanering.com\/blog\/en\/weight-loss\/weight-loss-injections-thyroid-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/clinicanering.com\/blog\/"},{"@type":"ListItem","position":2,"name":"Do Ozempic and Mounjaro Cause Thyroid Cancer? What the Studies Show"}]},{"@type":"WebSite","@id":"https:\/\/clinicanering.com\/blog\/#website","url":"https:\/\/clinicanering.com\/blog\/","name":"Cl\u00ednica Nering","description":"Performance e Sa\u00fade","publisher":{"@id":"https:\/\/clinicanering.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/clinicanering.com\/blog\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/clinicanering.com\/blog\/#organization","name":"Cl\u00ednica Nering","url":"https:\/\/clinicanering.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/clinicanering.com\/blog\/#\/schema\/logo\/image\/","url":"https:\/\/blog.clinicanering.com\/wp-content\/uploads\/2025\/08\/Design-sem-nome.png","contentUrl":"https:\/\/blog.clinicanering.com\/wp-content\/uploads\/2025\/08\/Design-sem-nome.png","width":1563,"height":1563,"caption":"Cl\u00ednica Nering"},"image":{"@id":"https:\/\/clinicanering.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.instagram.com\/clinica.nering"]},{"@type":"Person","@id":"https:\/\/clinicanering.com\/blog\/#\/schema\/person\/7ad6b0ae64865ab53b092185769b59d3","name":"Dr. Gilberto Nering Junior","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/clinicanering.com\/wp-content\/themes\/Clinica%20Nering\/assets\/images\/relume-254303-p-800.jpeg","url":"https:\/\/clinicanering.com\/wp-content\/themes\/Clinica%20Nering\/assets\/images\/relume-254303-p-800.jpeg","contentUrl":"https:\/\/clinicanering.com\/wp-content\/themes\/Clinica%20Nering\/assets\/images\/relume-254303-p-800.jpeg","caption":"Dr. Gilberto Nering Junior"},"description":"M\u00e9dico do Esporte, Nutr\u00f3logo. Especialista em performance, emagrecimento e sa\u00fade metab\u00f3lica. Autor de \u201cO Guia Completo de Beach Tennis\u201d.","sameAs":["https:\/\/blog.clinicanering.com"],"url":"https:\/\/clinicanering.com\/blog\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/posts\/648","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/comments?post=648"}],"version-history":[{"count":5,"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/posts\/648\/revisions"}],"predecessor-version":[{"id":2001,"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/posts\/648\/revisions\/2001"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/media\/299"}],"wp:attachment":[{"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/media?parent=648"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/categories?post=648"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinicanering.com\/blog\/wp-json\/wp\/v2\/tags?post=648"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}